Literature DB >> 11368185

Inhibition of mono-ADP-ribosyltransferase activity during the execution phase of apoptosis prevents apoptotic body formation.

I J Lodhi1, R E Clift, G M Omann, J F Sweeney, K K McMahon, D B Hinshaw.   

Abstract

The objective of this study was to understand factors responsible for apoptotic body formation and release during apoptosis. We have found that inhibition of mono-ADP ribosylation after ultraviolet (UV) light induction of apoptosis in HL-60 cells does not block caspase-3 activation, gelsolin cleavage, or endonucleolytic DNA fragmentation. However, the cytoskeletal features of apoptosis leading to apoptotic body formation and release were inhibited by meta-iodobenzylguanidine (MIBG) and novobiocin, potent inhibitors of arginine-specific mono-ADP-ribosyltransferases (mono-ADPRTs). Suppression of mono-ADP ribosylation as late as 120 min following UV irradiation blocked the depolymerization of actin and release of apoptotic bodies. This suggested that the cytoskeletal changes of apoptosis may be decoupled from the caspase cascade and that there may be a biochemical event either distal to or independent of caspase-3 that regulates apoptotic body formation. To test the hypothesis that ADP ribosylation of actin may occur with the induction of apoptosis, an in vivo assay of mono-ADPRT activity using an antibody against ADP-ribosylarginine was used. An approximately 64% increase in the ADP ribosylation of actin was observed at 2 h following exposure to UV light. When MIBG or novobiocin was present, the ADP ribosylation of actin was only 14-18% above the levels observed in control nonirradiated cells. The current study is the first to demonstrate a relationship between ADP-ribosylation of actin and the formation of apoptotic bodies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368185     DOI: 10.1006/abbi.2000.2215

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Mono ADP-ribosylation inhibitors prevent inflammatory cytokine release in alveolar epithelial cells.

Authors:  Mariangela Del Vecchio; Enrico Balducci
Journal:  Mol Cell Biochem       Date:  2007-12-09       Impact factor: 3.396

2.  The expression pattern of ADP-ribosyltransferase 3 in rat traumatic brain injury.

Authors:  Wei Shi; Peipei Gong; Jian Fan; Yao Hua Yan; Lanchun Ni; Xiaohong Wu; Gang Cui; Xinmin Wu; Xingxing Gu; Jian Chen
Journal:  J Mol Histol       Date:  2011-10-26       Impact factor: 2.611

Review 3.  Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?

Authors:  Paul O Hassa; Sandra S Haenni; Michael Elser; Michael O Hottiger
Journal:  Microbiol Mol Biol Rev       Date:  2006-09       Impact factor: 11.056

Review 4.  Functional aspects of protein mono-ADP-ribosylation.

Authors:  Daniela Corda; Maria Di Girolamo
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

5.  ART3 regulates triple-negative breast cancer cell function via activation of Akt and ERK pathways.

Authors:  Ling Tan; Xiaodan Song; Xin Sun; Ning Wang; Ying Qu; Zhijun Sun
Journal:  Oncotarget       Date:  2016-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.